½ÃÀ庸°í¼­
»óǰÄÚµå
1813908

º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À̹Ì¡ ¸ð´Þ¸®Æ¼º°, Àü°³ ¹æ½Äº°, ±¸¼º¿ä¼Òº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)

Vendor Neutral Archive Market Size, Share & Trends Analysis Report By Imaging Modalities, By Deployment Mode, By Component, By End Use, By Application, By Region, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå ¿ä¾à

¼¼°è º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå ±Ô¸ð´Â 2024³â 29¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2025³âºÎÅÍ 2033³â±îÁö CAGR 13.3%·Î ¼ºÀåÇÏ¿© 88¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¿©·¯ Áø·á°ú(¿µ»óÀÇÇаú, ¼øÈ¯±â³»°ú, º´¸®°ú, ¾È°ú)¿¡ °ÉÄ£ ¿öÅ©Ç÷οìÀÇ ¿µ»ó 󸮷® Áõ°¡¿Í M&A ½Ã ·¹°Å½Ã PACS¿¡ ÀÇÇØ Çü¼ºµÈ »çÀϷθ¦ ÅëÇÕÇÒ Çʿ伺¿¡ ±âÀÎÇÕ´Ï´Ù.

CIO´Â À̹ÌÁö¿Í dzºÎÇÑ ¸ÞŸµ¥ÀÌÅͰ¡ EHR°ú ´Ù¿î½ºÆ®¸² ºÐ¼®¿¡ ¿øÈ°ÇÏ°Ô À¯À﵃ ¼ö ÀÖµµ·Ï »óÈ£¿î¿ë¼º-DICOM, HL7/FHIR, IHE-XDS-À» ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ¸¶À̱׷¹À̼ǰú ÇÏÀ̺긮µå ½ºÅ丮Áö ¸ðµ¨Àº ÃѼÒÀ¯ºñ¿ë(TCO)À» Àý°¨ÇÏ´Â µ¿½Ã¿¡ È®À强, ÀçÇØ º¹±¸, »çÀ̹ö ÀúÇ×¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. Àå±â º¸°ü°ú °­È­µÈ µ¥ÀÌÅÍ °Å¹ö³Í½º ±ÔÄ¢(°¨»ç °¡´É¼º, ÇÁ¶óÀ̹ö½Ã, µ¥ÀÌÅÍ ·¹Áö´ø½Ã)Àº ¾ÖÇø®ÄÉÀ̼ǰú ¿¬°èµÈ ¾ÆÄ«À̺꺸´Ù º¥´õ Á߸³ ¾ÆÄ«À̺ê(NVA)¿¡ À¯¸®ÇÕ´Ï´Ù.

ÃÖ±Ù ÁÖ¿ä ÇコÄɾî IT ±â¾÷ÀÇ Çõ½Å°ú Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê´Â VNAÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù ÈÄÁöÇʸ§ÀÇ ½Ã³À½º VNA´Â ³ôÀº »óÈ£¿î¿ë¼º°ú °í°´ ¸¸Á·µµ¸¦ ÀÎÁ¤¹Þ¾Æ 5³â ¿¬¼Ó KLAS ÃÖ¿ì¼ö»óÀ» ¼ö»óÇß½À´Ï´Ù. ¸¶Âù°¡Áö·Î GEÇコÄɾî´Â 2024³â 3¿ù, º¥´õ Á߸³ ¾ÆÄ«ÀÌºê µ¥ÀÌÅ͸¦ GEÀÇ ¿¡µð½¼ VNA Ç÷§Æû¿¡ ÅëÇÕÇÏ¿© º¥´õ Á߸³ ¾ÆÄ«À̺긦 ÃßÁøÇϱâ À§ÇØ Æ®¶óÀ̹ø Çコ¿ÍÀÇ Çù·ÂÀ» ¹ßÇ¥Çß½À´Ï´Ù. À̹ø Á¦ÈÞ´Â »óÈ£ ¿î¿ë¼ºÀ» °­È­Çϰí ÀÓ»óÀÇ¿¡°Ô º¸´Ù Á¾ÇÕÀûÀΠȯÀÚ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¹ßÀüÀ» ¹ÙÅÁÀ¸·Î VNA ½ÃÀåÀº È®À强, º¸¾È, ½Ç½Ã°£ µ¥ÀÌÅÍ ¾×¼¼½º °­È­¿¡ ÁßÁ¡À» µÐ ´õ Å« Ŭ¶ó¿ìµå ÅëÇÕÀ¸·ÎÀÇ ÀüȯÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. »óÈ£¿î¿ë¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ±â°üÀº ¼­·Î ´Ù¸¥ ½Ã½ºÅÛ °£¿¡ ¿µ»ó µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô °ü¸®ÇÏ°í °øÀ¯ÇÒ ¼ö ÀÖ°Ô µÇ¾î Çù¾÷°ú È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ º¸´Ù À¯¿¬Çϰí ÅëÇÕµÈ ¼Ö·ç¼ÇÀ» äÅÃÇÔ¿¡ µû¶ó VNA´Â Á¤¹Ð ÀǷḦ Áö¿øÇϰí, ÀÓ»ó ÀÇ»ç°áÁ¤À» °­È­Çϸç, ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ¾÷°è ±âȸ ºÐ¼®
    • ¾÷°è °úÁ¦ ºÐ¼®
    • »ç·Ê ¿¬±¸
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : À̹Ì¡ ¸ð´Þ¸®Æ¼ ÃßÁ¤¡¤µ¿Ç⠺м®

  • À̹Ì¡ ¸ð´Þ¸®Æ¼ ºÎ¹® ´ë½Ãº¸µå
  • À̹Ì¡ ¸ð´Þ¸®Æ¼ ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, À̹Ì¡ ¸ð´Þ¸®Æ¼º°, 2021-2033³â
    • ¹æ»ç¼±°ú
    • ½ÉÀ庴ÇÐ
    • º´¸®ÇÐ
    • ³»½Ã°æ °Ë»ç
    • ¸¾¸ð±×·¡ÇÇ
    • ±âŸ

Á¦5Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : Àü°³ ¹æ½Ä ÃßÁ¤¡¤µ¿Ç⠺м®

  • Àü°³ ¹æ½Ä ´ë½Ãº¸µå
  • Àü°³ ¹æ½Ä ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, Àü°³ ¹æ½Äº°, 2021-2033³â
  • ¿ÂÇÁ·¹¹Ì½º
    • ¿ÂÇÁ·¹¹Ì½º ½ÃÀå, 2021-2033³â
  • Ŭ¶ó¿ìµå ±â¹Ý
    • Ŭ¶ó¿ìµå ±â¹Ý ½ÃÀå, 2021-2033³â
  • ÇÏÀ̺긮µå
    • ÇÏÀ̺긮µå ½ÃÀå, 2021-2033³â

Á¦6Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : ±¸¼º¿ä¼Ò ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÄÄÆ÷³ÍÆ® ºÎ¹® ´ë½Ãº¸µå
  • ÄÄÆ÷³ÍÆ® ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, ±¸¼º¿ä¼Òº°, 2021-2033³â
  • ¼ÒÇÁÆ®¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, 2021-2033³â
  • ¼­ºñ½º
    • ¼­ºñ½º ½ÃÀå, 2021-2033³â

Á¦7Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2021-2033³â
  • º´¿ø
    • º´¿ø ½ÃÀå, 2021-2033³â
  • Áø´Ü ¿µ»ó ¼¾ÅÍ
    • Áø´Ü ¿µ»ó ¼¾ÅÍ ½ÃÀå, 2021-2033³â
  • ±âŸ
    • ±âŸ ½ÃÀå, 2021-2033³â

Á¦8Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ¿ëµµ ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®, ¿ëµµº°, 2021-2033³â
  • ÀÓ»ó ¿µ»ó
    • ÀÓ»ó ¿µ»ó ½ÃÀå, 2021-2033³â
  • ºñÀÓ»ó µ¥ÀÌÅÍ °ü¸®
    • ºñÀÓ»ó µ¥ÀÌÅÍ °ü¸® ½ÃÀå, 2021-2033³â

Á¦9Àå º¥´õ Á߸³ ¾ÆÄ«ÀÌºê ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • Áö¿ª ½ÃÀå : ÁÖ¿ä Æ÷ÀÎÆ®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦10Àå °æÀï ±¸µµ

  • Âü¿©ÀÚ °³¿ä
  • ±â¾÷ ½ÃÀå »óȲ ºÐ¼®/Á¡À¯À² ºÐ¼®, 2024³â
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • GE HealthCare
    • Siemens Healthineers International AG
    • FUJIFILM Corporation
    • Koninklijke Philips NV,
    • IBM Watson Health(Merative)
    • Hyland Healthcare
    • Sectra AB
    • Agfa HealthCare
    • Carestream Health
    • BridgeHead Software
    • Canon Medical Systems
    • Novarad
    • Dell Technologies
    • Change Healthcare
    • Dicom Systems, Inc.
    • Intelerad
    • RamSoft
KSM 25.09.26

Vendor Neutral Archive Market Summary

The global vendor neutral archive market size was estimated at USD 2.94 billion in 2024 and is expected to reach USD 8.89 billion, growing at a CAGR of 13.3% from 2025 to 2033. This growth is driven by the increasing imaging volumes across multi-ology workflows (radiology, cardiology, pathology, ophthalmology), and the need to consolidate silos created by legacy PACS during M&A.

CIOs are prioritizing interoperability-DICOM, HL7/FHIR, and IHE-XDS-so images and rich metadata flow seamlessly into EHRs and downstream analytics. Cloud migration and hybrid storage models are reducing the total cost of ownership while improving scalability, disaster recovery, and cyber-resilience, which is a board-level concern after high-profile ransomware events. Long-term retention and tightening data-governance rules (auditability, privacy, data residency) favor vendor neutral archive (VNAs) over application-tied archives.

Recent innovations and strategic initiatives from leading healthcare IT companies further propel the adoption of VNAs. For instance, in February 2024, Fujifilm's Synapse VNA was named best in KLAS for the fifth consecutive year, recognizing its interoperability and customer satisfaction excellence. Similarly, in March 2024, GE HealthCare announced a collaboration with Tribun Health to advance Vendor Neutral Archive by integrating Vendor Neutral Archive data into GE's Edison VNA platform. This partnership aims to enhance interoperability and provide clinicians with a more comprehensive view of patient data.

Building on these advancements, the VNA market is witnessing a shift towards greater cloud integration, focusing on enhancing scalability, security, and real-time data access. The growing emphasis on interoperability enables healthcare organizations to seamlessly manage and share imaging data across different systems, improving collaboration and efficiency. As healthcare providers adopt more flexible and integrated solutions, VNAs play a critical role in supporting precision medicine, enhancing clinical decision-making, and streamlining workflows across various healthcare settings.

Global Vendor Neutral Archive Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the vendor neutral archive market based on imaging modalities, deployment mode, component, end use, application, and region:

  • Imaging Modalites Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiology
  • Cardiology
  • Pathology
  • Endoscopy
  • Mammography
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • On-premise
  • Cloud-based
  • Hybrid
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Imaging Centers
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Imaging
  • Non-clinical Data Management
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Imaging Modalities
    • 1.2.2. Deployment Mode
    • 1.2.3. Component
    • 1.2.4. End use
    • 1.2.5. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing data security and privacy concerns
      • 3.2.1.2. Increasing volume of medical imaging data
      • 3.2.1.3. Need for Interoperability
      • 3.2.1.4. Rise in Tele radiology and Remote Diagnostics
      • 3.2.1.5. Growing usage of AI/ML in vendor neutral archive systems
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Implementation cost
      • 3.2.2.2. Complexity of Data Migration from PACS to a VNA
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Vendor Neutral Archive Market: Imaging Modalities Estimates & Trend Analysis

  • 4.1. Imaging Modalities Segment Dashboard
  • 4.2. Imaging Modalities Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Imaging Modalities , 2021 to 2033 (USD Million)
    • 4.3.1. Radiology
      • 4.3.1.1. Radiology market, 2021 - 2033 (USD Million)
    • 4.3.2. Cardiology
      • 4.3.2.1. Cardiology market, 2021 - 2033 (USD Million)
    • 4.3.3. Pathology
      • 4.3.3.1. Pathology market, 2021 - 2033 (USD Million)
    • 4.3.4. Endoscopy
      • 4.3.4.1. Endoscopy market, 2021 - 2033 (USD Million)
    • 4.3.5. Mamography
      • 4.3.5.1. Mamography market, 2021 - 2033 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Others market, 2021 - 2033 (USD Million)

Chapter 5. Vendor Neutral Archive Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 5.4. On-premise
    • 5.4.1. On-premise market, 2021 - 2033 (USD Million)
  • 5.5. Cloud-based
    • 5.5.1. Cloud-based market, 2021 - 2033 (USD Million)
  • 5.6. Hybrid
    • 5.6.1. Hybrid market, 2021 - 2033 (USD Million)

Chapter 6. Vendor Neutral Archive Market: Component Estimates & Trend Analysis

  • 6.1. Component Segment Dashboard
  • 6.2. Component Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 6.4. Software
    • 6.4.1. Software market, 2021 - 2033 (USD Million)
  • 6.5. Services
    • 6.5.1. Services market, 2021 - 2033 (USD Million)

Chapter 7. Vendor Neutral Archive Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use , 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market, 2021 - 2033 (USD Million)
  • 7.5. Diagnostic Imaging Centers
    • 7.5.1. Diagnostic Imaging Centers market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market, 2021 - 2033 (USD Million)

Chapter 8. Vendor Neutral Archive Market: Application Estimates & Trend Analysis

  • 8.1. Application Segment Dashboard
  • 8.2. Application Market Share Movement Analysis, 2024 & 2033
  • 8.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 8.4. Clinical Imaging
    • 8.4.1. Clinical Imaging market, 2021 - 2033 (USD Million)
  • 8.5. Non-clinical Data Management
    • 8.5.1. Non-clinical Data Management market, 2021 - 2033 (USD Million)

Chapter 9. Vendor Neutral Archive Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Dashboard
  • 9.2. Regional Market: Key Takeaways
  • 9.3. North America
    • 9.3.1. North America Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamic
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Competitive insights
      • 9.3.2.4. U.S. Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamic
      • 9.3.3.2. Regulatory framework
      • 9.3.3.3. Competitive insights
      • 9.3.3.4. Canada Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamic
      • 9.3.4.2. Regulatory framework
      • 9.3.4.3. Competitive insights
      • 9.3.4.4. Mexico Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamic
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive insights
      • 9.4.2.4. Germany Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. UK
      • 9.4.3.1. Key country dynamic
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive insights
      • 9.4.3.4. UK Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamic
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive insights
      • 9.4.4.4. France Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamic
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Competitive insights
      • 9.4.5.4. Italy Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamic
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Competitive insights
      • 9.4.6.4. Spain Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key country dynamic
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Competitive insights
      • 9.4.7.4. Denmark Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key country dynamic
      • 9.4.8.2. Regulatory framework
      • 9.4.8.3. Competitive insights
      • 9.4.8.4. Sweden Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamic
      • 9.4.9.2. Regulatory framework
      • 9.4.9.3. Competitive insights
      • 9.4.9.4. Norway Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key country dynamic
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive insights
      • 9.5.2.4. Japan Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamic
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive insights
      • 9.5.3.4. China Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key country dynamic
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive insights
      • 9.5.4.4. India Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamic
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive insights
      • 9.5.5.4. South Korea Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key country dynamic
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive insights
      • 9.5.6.4. Australia Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.7. Thailand
      • 9.5.7.1. Key country dynamic
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive insights
      • 9.5.7.4. Thailand Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Vendor Neutral Archive Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key country dynamic
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive insights
      • 9.6.2.4. Brazil Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamic
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive insights
      • 9.6.3.4. Argentina Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key country dynamic
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive insights
      • 9.7.2.4. South Africa Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key country dynamic
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive insights
      • 9.7.3.4. Saudi Arabia Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key country dynamic
      • 9.7.4.2. Regulatory framework
      • 9.7.4.3. Competitive insights
      • 9.7.4.4. UAE Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key country dynamic
      • 9.7.5.2. Regulatory framework
      • 9.7.5.3. Competitive insights
      • 9.7.5.4. Kuwait Vendor Neutral Archive market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis/ Share Analysis 2024
  • 10.3. Company Categorization
  • 10.4. Company Profiles/Listing
    • 10.4.1. GE HealthCare
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Products & Services benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Siemens Healthineers International AG
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Products & Services benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. FUJIFILM Corporation
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Products & Services benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Koninklijke Philips N.V.,
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Products & Services benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. IBM Watson Health (Merative)
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Products & Services benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Hyland Healthcare
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Products & Services benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Sectra AB
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Products & Services benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Agfa HealthCare
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Products & Services benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Carestream Health
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Products & Services benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BridgeHead Software
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Products & Services benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Canon Medical Systems
      • 10.4.11.1. Overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Products & Services benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Novarad
      • 10.4.12.1. Overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Products & Services benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Dell Technologies
      • 10.4.13.1. Overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Products & Services benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Change Healthcare
      • 10.4.14.1. Overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Products & Services benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Dicom Systems, Inc.
      • 10.4.15.1. Overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Products & Services benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. Intelerad
      • 10.4.16.1. Overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Products & Services benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. RamSoft
      • 10.4.17.1. Overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Products & Services benchmarking
      • 10.4.17.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦